Tango Therapeutics, Inc.

Tango Therapeutics, Inc. financial statements

Tango Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 62.38M10-K
Net income−USD 101.59M10-K
Cash and equivalentsUSD 112.28M10-Q
Total debtUSD 33.57MEODHD

Tango Therapeutics, Inc. financials on 6ix · Tango Therapeutics, Inc. on 6ix